Woodline Partners’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-33,081
Closed -$3.33M 830
2021
Q3
$3.33M Sell
33,081
-5,950
-15% -$614K 0.05% 322
2021
Q2
$4.58M Sell
39,031
-37,337
-49% -$4.89M 0.09% 233
2021
Q1
$14.5M Buy
76,368
+41,857
+121% +$7.34M 0.32% 85
2020
Q4
$4.86M Sell
34,511
-39,543
-53% -$5.84M 0.13% 159
2020
Q3
$12.1M Buy
74,054
+37,642
+103% +$6.69M 0.4% 76
2020
Q2
$7.53M Buy
36,412
+20,316
+126% +$4.72M 0.3% 85
2020
Q1
$3.21M Buy
+16,096
New +$3.52M 0.23% 106

Other funds holding MTEM

Woodline Partners's MTEM Position: Q4 2021 in Review

Woodline Partners sold out of Molecular Templates, Inc. (MTEM) in Q4 2021, closing a stake of 33,081 shares — an estimated $3.33M sold.

Woodline Partners first reported a position in MTEM in Q1 2020 and held it in 7 quarters. The position peaked at $14.5M in Q1 2021. 79 funds tracked by Wall St. Rank hold MTEM as of Q4 2021.

  • Woodline Partners reported no remaining Molecular Templates, Inc. position as of Q4 2021 after selling out during the quarter.
  • Woodline Partners sold 33,081 Molecular Templates, Inc. shares in Q4 2021, an estimated $3.33M.
  • Woodline Partners first reported a position in Molecular Templates, Inc. in Q1 2020 and held it in 7 quarters.
  • Woodline Partners's Molecular Templates, Inc. position peaked at $14.5M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2021.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.